Core Viewpoint - Herbalife Ltd (HLF) shows potential for upside with a mean price target of $8.67, indicating a 28.8% upside from the current price of $6.73 [1] Price Targets and Estimates - The mean estimate consists of three short-term price targets with a standard deviation of $2.08, where the lowest estimate is $7 (4% increase) and the highest is $11 (63.5% increase) [2] - A low standard deviation suggests a high degree of agreement among analysts regarding the stock's price movement [9] Analyst Sentiment and Earnings Estimates - Analysts are optimistic about HLF's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which has shown a strong correlation with near-term stock price movements [11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 9.8%, with one estimate moving higher and no negative revisions [12] Zacks Rank and Investment Implications - HLF currently holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be reliable for predicting the extent of gains, they can provide a directional guide for potential price movement [13]

Core Viewpoint - NewAmsterdam Pharma Company N.V. (NAMS) has shown a significant price increase of 21.5% over the past four weeks, with a mean price target of $42.71 indicating a potential upside of 132.5% from the current price of $18.37 [1] Price Targets and Analyst Consensus - The average price target consists of seven estimates ranging from a low of $37 to a high of $52, with a standard deviation of $5.28, suggesting a high degree of agreement among analysts [2] - The lowest estimate indicates a potential increase of 101.4%, while the most optimistic estimate suggests an upside of 183.1% [2] - Analysts' price targets should be approached with caution, as empirical research indicates they often mislead investors rather than provide accurate guidance [7][10] Earnings Estimates and Market Sentiment - Analysts are optimistic about NAMS's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which historically correlates with stock price movements [4][11] - Over the past 30 days, one earnings estimate has increased, leading to a 3.8% rise in the Zacks Consensus Estimate for the current year [12] - NAMS holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, further supporting its potential upside [13]

Group 1 - Concentra Group (CON) closed at $21.40, with a 5.5% gain over the past four weeks, and a mean price target of $28 suggests a 30.8% upside potential [1] - The average price targets range from $25 to $30, with a standard deviation of $1.85, indicating a low variability among analysts' estimates [2] - Analysts are optimistic about CON's earnings prospects, with a positive trend in earnings estimate revisions, which historically correlates with stock price movements [4][11] Group 2 - The Zacks Consensus Estimate for the current year has increased by 1.5% over the past month, with three estimates revised higher and no negative revisions [12] - CON holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While the consensus price target may not be a reliable indicator of the stock's potential gain, it does suggest a positive direction for price movement [13]

ODP Corp. (ODP) closed the last trading session at $17.18, gaining 27.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $31 indicates an 80.4% upside potential.The mean estimate comprises three short-term price targets with a standard deviation of $12.49. While the lowest estimate of $17 indicates a 1.1% decline from the current price level, the most optimistic analyst expects the ...

IonQ, Inc. (IONQ) closed the last trading session at $31.27, gaining 19.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $40 indicates a 27.9% upside potential.The mean estimate comprises five short-term price targets with a standard deviation of $7.91. While the lowest estimate of $30 indicates a 4.1% decline from the current price level, the most optimistic analyst expects the ...

Investors might want to bet on Palantir Technologies Inc. (PLTR) , as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.Indiv ...

Core Viewpoint - Priority Technology (PRTH) has been upgraded to a Zacks Rank 1 (Strong Buy), indicating a positive outlook based on rising earnings estimates, which significantly influence stock prices [1][3]. Earnings Estimates and Stock Price Impact - The Zacks rating system emphasizes the importance of earnings estimate revisions, which have a strong correlation with near-term stock price movements [4][6]. - An increase in earnings estimates typically leads to higher fair value calculations by institutional investors, resulting in buying or selling actions that affect stock prices [4]. Company Performance Indicators - For the fiscal year ending December 2025, Priority Technology is projected to earn $1.06 per share, reflecting a 107.8% increase from the previous year [8]. - Over the past three months, the Zacks Consensus Estimate for Priority Technology has risen by 39.5%, indicating a positive trend in earnings expectations [8]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with Zacks Rank 1 stocks historically generating an average annual return of +25% since 1988 [7]. - The upgrade of Priority Technology to Zacks Rank 1 places it in the top 5% of Zacks-covered stocks, suggesting potential for market-beating returns in the near term [10].

Group 1 - Shares of Braze, Inc. (BRZE) have increased by 10.8% over the past four weeks, closing at $33.66, with a mean price target of $51.37 indicating a potential upside of 52.6% [1] - The mean estimate consists of 19 short-term price targets with a standard deviation of $10.18, where the lowest estimate is $38 (12.9% increase) and the highest is $75 (122.8% increase) [2] - Analysts show strong agreement in revising earnings estimates higher, which correlates with potential stock price movements [11][12] Group 2 - The Zacks Consensus Estimate for the current year has risen by 0.7% over the past month, with two estimates increasing and one decreasing [12] - BRZE holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While the consensus price target may not be a reliable indicator of the stock's potential gain, it suggests a positive direction for price movement [13]

Copa Holdings (CPA) closed the last trading session at $100.68, gaining 19% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $150.45 indicates a 49.4% upside potential.The mean estimate comprises 11 short-term price targets with a standard deviation of $20.25. While the lowest estimate of $120 indicates a 19.2% increase from the current price level, the most optimistic analyst expec ...

Roku (ROKU) closed the last trading session at $61.36, gaining 3.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $88.87 indicates a 44.8% upside potential.The mean estimate comprises 26 short-term price targets with a standard deviation of $17.78. While the lowest estimate of $60 indicates a 2.2% decline from the current price level, the most optimistic analyst expects the stock ...